The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee March 2026 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its March 2026 meeting and NICE Technology appraisals from the 1st December 2025 to 31st January 2026.
The following new guidelines were approved and can be found at:
- NENC Oral Antipsychotics – Safe Prescribing – https://ntag.nhs.uk/wp-content/uploads/2026/03/NENC-Oral-antipsychotics-Safe-Prescribing-v1-approved-March-2026.pdf
The following reviewed guidelines were approved and can be found at:
- NENC Clozapine Supporting guidance for primary care – updates per March 2026 CEG decision summary https://ntag.nhs.uk/wp-content/uploads/2026/03/NENC-Clozapine-Supporting-guidance-for-primary-care-v2-approved-March-2026.pdf
- Finerenone for treating chronic kidney disease in people with type 2 diabetes – no updates made https://ntag.nhs.uk/wp-content/uploads/2026/03/NENC-Finerenone_CKD_type-2-diabetes_v6-approved-March-2026.pdf
The following updated guidelines were approved and can be found at:
- North East North Cumbria (NENC) ICB Medicines Committee Position Statement on Prescribing in Persistent Pain – updates per March 2026 CEG decision summary. Updated to reflect updated Opioids Aware guidance from Faculty of Pain Medicine https://ntag.nhs.uk/wp-content/uploads/2026/03/NENC-ICB-position-statement-non-palliative-care-use-of-opiates-update-Feb-2026.pdf
- NENC guideline for management of osteoporosis in primary care – updates per March 2026 CEG decision summary. https://ntag.nhs.uk/wp-content/uploads/2026/03/NENC-ICS-guideline-for-management-of-osteoporosis-in-primary-care-approved-Jan-2026-v9.1-updated-March-2026.pdf
The following new shared care guidelines were approved and can be found at:
- NENC Valproate SCG https://ntag.nhs.uk/shared-care-guidelines/
The following reviewed and updated shared care guidelines were approved and can be found at:
- NENC Shared Care Protocol – Amiodarone for patients in adult services – technical updates as per change table on front page and March 2026 CEG decision summary. https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Dronedarone for patients in adult services technical updates as per change table on front page and March 2026 CEG decision summary. https://ntag.nhs.uk/shared-care-guidelines/
The following shared care guidelines have had their review date extended:
- NENC Shared Care Protocol – Lithium for adult patients within mental health services – extended to July 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Azathioprine and mercaptopurine within adult services (non-transplant indications) – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Ciclosporin (oral) for patients within adult services (non-transplant indications) – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Hydroxychloroquine for patients within adult services – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Leflunomide for patients within adult services – – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care) – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Mycophenolate mofetil and mycophenolic acid in adults (non-transplant indications) – extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Sulfasalazine for patients within adult services- extended to September 2026 https://ntag.nhs.uk/shared-care-guidelines/